Key facts
- Cormorant Asset Management is a venture capital firm based in Boston, MA with 39 tracked portfolio companies.
- Notable positions include Freenome, Neurona Therapeutics, Parabilis Medicines, Tessera Therapeutics, Latigo Bio.
- Cormorant Asset Management reports $773.0M in regulatory assets under management across 7 private funds, per its SEC Form ADV (2026-03).
Registered with the SEC
Form ADV · 2026-03 · CRD 167820- Regulatory AUM
- $773.0M
- Private fund assets
- $3.8B
- Private funds
- 7 · 6 private equity, 1 hedge
- Staff
- 12
- Registered office
- BOSTON, MA
- SEC status
- Approved
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as CORMORANT ASSET MANAGEMENT, LP).
Free account
See the whole book
- ·The book's top 25 — of 39 recorded positions
- ·Watchlist + alerts for Cormorant Asset Management's activity
Create free account
No card required
Portfolio, priced
39 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | $2.2B | — | |
| Neurona Therapeutics | Drug Discovery | $1.1B | — | |
| Parabilis Medicines | Drug Discovery | $920.0M | — | |
| Tessera Therapeutics | — | $650.0M | — | |
| Latigo Bio | — | $530.0M | — | |
| Electra Therapeutics | Drug Discovery | $479.0M | — | |
| Supira Medical | — | $445.0M | — | |
| Umoja Biopharma | — | $420.0M | — | |
| AgomAb | Drug Discovery | $415.6M | — | |
| BlossomHill Therapeutics | — | $413.1M | — | |
| Attovia Therapeutics | — | $370.0M | — | |
| Interius BioTherapeutics | — | $350.0M | — | |
| Aspen Neuroscience | — | $346.0M | — | |
| Third Arc Bio | — | $314.0M | — | |
| Triveni Bio | Drug Discovery | $310.0M | — | |
| + 24 more companies · a free account shows the top of the book | ||||
Frequently asked
- What companies does Cormorant Asset Management invest in?
- Cormorant Asset Management has 39 recorded portfolio companies, including Freenome, Neurona Therapeutics, Parabilis Medicines, Tessera Therapeutics.